Anika Therapeutics Inc (ANIK) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Anika Therapeutics Inc   (NASDAQ: ANIK)
 

Anika Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Anika Therapeutics Inc 's inventory turnover ratio sequentially decreased to 1.83 in the third quarter 2026, otherwise the ratio remained above the average, as ANIK's markets remain strong.Anika Therapeutics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 199 days, from 171 days, in the Jun 30 2026 quarter.

Within Healthcare sector 188 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1252 in the second quarter 2026, to 1382.

ANIK Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Anika Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ANIK Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 86.39 % 68.8 % 7.04 % -21.09 % -58.91 %
Y / Y Cost of Sales Growth -2.03 % -12.57 % -9.09 % - 18.21 %
Inventory Turnover Ratio (TTM) 1.83 2.14 2.57 2.67 0.62
ANIK's Total Ranking # 1382 # 1252 # 1066 # 712 #
Average inventory processing period 199 170 142 137 589
Seq. Inventory Growth 6.25 % 25.08 % 21.56 % 15.37 % -3.77 %
Seq. Cost of Sales Growth 3.44 % 13.66 % -23.08 % 8.33 % -7.69 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 80
Healthcare Sector # 189
Overall Market # 1382

Inventory Turnover Ratio Statistics
High Average Low
3.31 1.63 0.16
(Jun 30 2012)   (Dec 31 2024)



ANIK Company Profile >> Back to ANIK Efficiency Comparisons >> Compare ANIK Inventory Turnover Ratio to its Competitors

Financial Statements
Anika Therapeutics Inc 's Inventories $ 30 Millions Visit ANIK's Balance sheet
Anika Therapeutics Inc 's Cost of Revenues TTM $ 46 Millions Visit ANIK's Income Statement
What are ANIK's Sales? Visit ANIK's Sales by Segment

Other Inventory Turnover Ratios
Anika Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ANIK's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ANIK's Competitors
Inventory Turnover Ratio for ANIK's Suppliers
Inventory Turnover Ratio for ANIK's Customers

You may also want to know
ANIK's Sales Growth Rates ANIK's Pe Price to earnings ratio ANIK's Receivables Turnover Ratio ANIK's Stock Quote
ANIK's Net Income Growth Rates ANIK's Ps Price to Sales ratio ANIK's Sales per Employee ANIK's Asset Turnover Ratio
ANIK's Net Margin ANIK's Pb Price to Book ratio ANIK's Financial Strength Ratios ANIK's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Electromed Inc   4.18 $ 14.878  Millions$ 4  Millions
Intelligent Bio Solutions Inc   4.14 $ 2.206  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Sonoma Pharmaceuticals Inc   3.90 $ 14.275  Millions$ 4  Millions
Koru Medical Systems Inc   3.88 $ 16.831  Millions$ 4  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Coherus Oncology inc   3.50 $ 16.193  Millions$ 5  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Elite Pharmaceuticals Inc   3.48 $ 80.918  Millions$ 23  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Iovance Biotherapeutics inc   3.21 $ 177.232  Millions$ 55  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Abbott Laboratories  2.95 $ 20,765.000  Millions$ 7,032  Millions
Revvity Inc  2.93 $ 1,122.448  Millions$ 384  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Zai Lab Limited  2.91 $ 200.083  Millions$ 69  Millions
Amneal Pharmaceuticals Inc   2.90 $ 1,910.255  Millions$ 658  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Ani Pharmaceuticals Inc  2.87 $ 405.540  Millions$ 142  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Dentsply Sirona Inc   2.65 $ 1,769.000  Millions$ 668  Millions
Sanara Medtech Inc   2.63 $ 9.086  Millions$ 3  Millions

Date modified: 2026-11-08T13:37:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.